fashion -WSS

fashion

author：entertainment 2025-10-01 17:35:15 - browse：384

Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks — the condition’s hallmark symptom — virtually eliminated for an average of 20 months and counting.

The attacks were reduced by an average of 98%. One patient has remained attack-free for 26 months. Two patients who suffered particularly frequent attacks, experiencing 14 and 16.8 per month, respectively, have now gone more than 20 months since their last attack.

No patient has had an attack in the last 11 months of follow-up, according to the data presented at the European Academy of Allergy and Clinical Immunology Congress. All side effects were either grade 1 or 2 on a 5-grade scale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Making AI in medicine accessible to smaller, and rural hospitals

focus

WSS

Use wet bulb globe temperature, not heat index, to protect workers

Bird flu outbreak in cows is latest avian flu curveball

Google says AlphaFold 3 can map a vast universe of biomolecules

Canadians with cystic fibrosis outlive Americans by a decade

Readout LOUD podcast: What to know about H5N1 bird flu

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

explore

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Peter Hotez and the public health issue of online harassment

Bird flu outbreak in cows is latest avian flu curveball

ChatGPT in medicine: STAT answers readers' burning questions

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Dobbs anniversary: the lost opportunity of abortion as health care

Study: AI not yet building 'n

Hepatitis C has a cure — but many Americans still lack access to it

Readout LOUD podcast: What to know about H5N1 bird flu

Dobbs anniversary: the lost opportunity of abortion as health care

Researchers on aging grapple with how to calculate biological age

focus

Shionogi licenses Pompe disease therapy from Maze Therapeutics

H5N1 bird flu: what we're starting to learn about infection in cows

Drug cartel violence flares in western Mexico after vigilante leader's killing

Brain worms: The science behind RFK Jr.'s parasitic infection

First recipient of genetically engineered pig kidney has died

After gene therapy, two congenitally deaf children hear for the first time

focus

focus

focus

hotspot